Peaks of Interest
Eksigent (Dublin, California) announced a new distribution agreement with Presearch (Hampshire, United Kingdom). The agreement reportedly covers sales of Eksigent's NanoLC HPLC product line in the United Kingdom and Ireland.
Eksigent announces distribution agreement with Presearch
Eksigent (Dublin, California) announced a new distribution agreement with Presearch (Hampshire, United Kingdom). The agreement reportedly covers sales of Eksigent's NanoLC HPLC product line in the United Kingdom and Ireland.
Presearch specializes in providing solutions and service to analytical and life science research customers. The company's offerings include HPLC, GC, flash chromatography, precision fluid delivery, and organoleptic sensors. Presearch has a base of several hundred customers, including top pharmaceutical companies in the UK.
Waters and Prosolia announce collaboration
Waters Corporation (Milford, Massachusetts) and Prosolia, Inc. (Indianapolis, Indiana) announced a collaboration to develop models of Prosolia's Omni Spray Ion Source that are compatible with Waters mass spectrometers.
The instrument from Prosolia has applications in drug discovery, in situ analysis of biological tissues and other fragile surfaces, as well as in homeland security and environmental monitoring.
"We are delighted with the opportunity to work with Waters in making DESI available for their instruments," stated Kevin Boscacci, president of Prosolia. "Our development time will be cut in half by having Waters support."
Agilent Technologies and Groton Biosystems sign agreement
Agilent Technologies Inc. (Santa Barbara, California) and Groton Biosystems LLC (Boxborough, Massachusetts) announced an agreement to co-market solutions for the Process Analytical Technology (PAT) Initiative for the pharmaceutical industry in the United States and Canada.
PAT is a system for designing, analyzing, and controlling manufacturing by measuring critical quality and performance attributes of raw and in-process materials and processes with the goal of ensuring final product quality.
The alliance is designed to benefit biopharmaceutical customers who perform in-process and final product testing in a wide range of production segments.
The agreement, expected to expand to Europe and Asia in the near future, brings together Agilent's HPLC systems with Groton Biosystems' strong online sampling products and services.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
